During the past decade, Hospital Central Dr Ignacio Morones Prieto conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 18 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Central Dr Ignacio Morones Prieto" #1 sponsor was "Universidad Autonoma de San Luis Potosí" with 22 trials, followed by "Hospital Central "Dr. Ignacio Morones Prieto"" with 6 trials sponsored, "Pfizer" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Central Dr Ignacio Morones Prieto" #1 collaborator was "Hospital Central "Dr. Ignacio Morones Prieto"" with 14 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Universidad Autonoma de San Luis Potosí" with 2 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 1 trials as a collaborator and "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Central Dr Ignacio Morones Prieto" are "Melasma" (4 trials), "Head Injury" (3 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials) and "Juvenile Idiopathic Arthritis" (2 trials). Many other conditions were trialed in "Hospital Central Dr Ignacio Morones Prieto" in a lesser frequency.

Most popular intervention types in "Hospital Central Dr Ignacio Morones Prieto" are "Drug" (46 trials), "Other" (7 trials), "Procedure" (5 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Rosuvastatin" (4 trials), "placebo" (4 trials), "Atorvastatin" (2 trials) and "Etanercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Central Dr Ignacio Morones Prieto" are 52 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Central Dr Ignacio Morones Prieto". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Hospital Central Dr Ignacio Morones Prieto, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Central Dr Ignacio Morones Prieto, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 4 trials that are defined as “Not Applicable".